Malaysia's sovereign wealth fund Khazanah Nasional Bhd is rebalancing its portfolio to invest more in developed markets, with ...

Asset values have stabilized, inflation has eased, and central banks are cutting rates which is emboldening real estate ...

Buch said that there has been significant misuse of IPO funds, often linked to related-party and layered transactions, ...

By monetising infrastructure, introducing diversified investment products, and transitioning long-term loans to the capital ...

Fintel reports that on January 21, 2025, Northland Capital Markets upgraded their outlook for LendingTree (NasdaqGS:TREE) ...

Sebi Chairperson Madhabi Puri Buch on Tuesday said the capital markets regulator has found "egregious misuse" of funds raised ...

To fund its ambitious revenue target of Rs 1,000 cr by 2029 Kinetic Engineering will issue convertible warrants worth Rs 177 crore, with a conversion period of 18 months. The promoters have committed ...

Our Investment Funds Group reviews the evolution of the continuation vehicle market and previews the unpredictable year awaiting the secondary market.

Bain Capital proposes to acquire minority stake in Dhoot Transmission, signaling investor interest in India's auto-component ...

Scottish Mortgage Investment Trust shares have provided huge returns over the last decade. Can they keep outperforming the ...

Investors considering alternative strategies should proactively adjust their portfolios to anticipate these potential changes ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.